Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Heart

• Publication date

  2012-08-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/heartjnl-2012-302346PMID 22936681
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Non-invasive assessment of interstitial myocardial fibrosis in pressure-overload left ventricular hypertrophy

  2012cited by this paper
• Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.

  2012cited by this paper
• Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging

  2012cited by this paper
• Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus

  2011cited by this paper
• Exercise training reduces fibrosis and matrix metalloproteinase dysregulation in the aging rat heart

  2011cited by this paper
• Assessment of myocardial fibrosis with cardiovascular magnetic resonance.

  2011cited by this paper
• THE MICROVASCULAR OBSTRUCTION WITH ACUTE MYOCARDIAL INFARCTION EVALUATED BY CARDIOVASCULAR MAGNETIC RESONANCE AS A REPERFUSION INJURY

  2011cited by this paper
• Sex and gender differences in myocardial hypertrophy and heart failure

  2011cited by this paper
• Association of Imaging Markers of Myocardial Fibrosis With Metabolic and Functional Disturbances in Early Diabetic Cardiomyopathy

  2011cited by this paper
• Identification of myocardial extracellular matrix expansion by cardiac MRI in hypertensive patients

  2011cited by this paper
• A detailed pathologic examination of heart tissue from three older patients with Anderson-Fabry disease on enzyme replacement therapy.

  2010cited by this paper
• Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold

  2010cited by this paper
• Anderson-Fabry disease and the heart.

  2010cited by this paper
• Fibrogenic reactions in lung disease.

  2010cited by this paper
• Nonalcoholic Fatty Liver Disease: A Review and Update

  2010cited by this paper
• Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans

  2010cited by this paper
• Heart transplant biopsies: interpretation and significance

  2009cited by this paper
• Association Between Elevated Fibrosis Markers and Heart Failure in the Elderly: The Cardiovascular Health Study

  2009cited by this paper
• Cellular and molecular mechanisms of fibrosis

  2008cited by this paper
• Complication Rate of Right Ventricular Endomyocardial Biopsy via the Femoral Approach: A Retrospective and Prospective Study Analyzing 3048 Diagnostic Procedures Over an 11-Year Period

  2008cited by this paper
• Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy.

  2008cited by this paper
• Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

  2007cited by this paper
• Amyloidosis.

  2006cited by this paper
• [Cellular and molecular mechanisms of fibrosis].

  2006cited by this paper
• Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies.

  2006cited by this paper
• Liver biopsy sampling in chronic viral hepatitis.

  2004cited by this paper
• Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis.

  2004cited by this paper
• Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.

  2003cited by this paper
• Age related changes of the collagen network of the human heart.

  2001cited by this paper
• The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

  2000cited by this paper
• The roles of gender, the menopause and hormone replacement on cardiovascular function.

  2000cited by this paper
• Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy.

  1999cited by this paper
• Age-related variation in the interstitial tissues of the cardiac conduction system; and autopsy study of 230 Han Chinese.

  1999cited by this paper
• Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats.

  1999cited by this paper
• The systemic amyloidoses.

  1997cited by this paper
• Imaging amyloidosis with radiolabelled SAP

  1995cited by this paper
• Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy.

  1991cited by this paper
• Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen.

  1990cited by this paper
• Myocardial fibrosis in the elderly.

  1990cited by this paper
• AMYLOID HEART DISEASE

  1949cited by this paper

• Translating Mechanistic Insights Into Action and Revealing New Pathways: Machine Learning Approaches in Heart Failure With Preserved Ejection Fraction.

  2026cites this paper
• Multiparametric CMR for detection of cardiac amyloidosis in patients with undifferentiated concentric left ventricular hypertrophy.

  2026cites this paper
• The role of quantitative cardiovascular MRI and late gadolinium enhancement patterns in differentiating late-onset Anderson-Fabry disease (c.640-801G > A) from hypertrophic cardiomyopathy: a case-control study.

  2026cites this paper
• Longitudinal observation of left ventricular inflow reorientation with preserved vorticity after myocardial infarction in a porcine model.

  2026cites this paper
• Cardiac Magnetic Resonance Imaging in the Evaluation and Prognosis of Infiltrative Cardiomyopathies

  2025cites this paper
• Myocardial fibrosis in severe asymptomatic versus symptomatic aortic stenosis: A cardiac magnetic resonance cross-sectional study

  2025cites this paper
• Cardiac MRI Protocols: Point-A Complex Organ With Complex Disease Should Be Studied Using Comprehensive Protocols.

  2025cites this paper
• Myocardial Amyloid Burden in Transthyretin Amyloidosis.

  2025cites this paper
• Photon-counting CT myocardial extracellular volume: A non-invasive biomarker for fibrosis in patients with hypertrophic cardiomyopathy.

  2025cites this paper
• All-in-One Cardiac MRI: Unified Non-Contrast-enhanced and Contrast-enhanced Imaging for a Continuous-Acquisition Examination.

  2025cites this paper
• Dual-layer spectral computed tomography (CT) parameters for identifying severe aortic regurgitation in aortic valve disease patients.

  2025cites this paper
• Prognostic value of CMR parametric mapping in cardiac amyloidosis: an updated systematic review and meta-analysis

  2025influential citation
• Myocardial extracellular volume fraction estimations using late enhancement CT in patients with atrial fibrillation: a comparative study with cardiac MR.

  2025cites this paper
• Long-Term Effect of Tafamidis on Clinical Parameters and Prognostic Predictors in Patients With Transthyretin Amyloid Cardiomyopathy.

  2025cites this paper
• Cardiovascular disease in Sickle cell: mechanisms, diagnostics and therapeutic advances

  2025cites this paper
• Cardiac magnetic resonance imaging in the follow-up of patients with Fabry cardiomyopathy.

  2025cites this paper
• Cardiac Magnetic Resonance in Heart Failure: Diagnostic and Prognostic Assessments

  2025cites this paper
• What Cardiologists Should Know About Amyloidosis

  2025cites this paper
• (The use of cardiac magnetic resonance in the stratification of patients with dilated cardiomyopathy)

  2025cites this paper
• Prognostic value of myocardial computed tomography–derived extracellular volume in severe aortic stenosis requiring aortic valve replacement: a systematic review and meta-analysis

  2025cites this paper
• Myocardial extracellular volume measurement using cardiac computed tomography

  2024cites this paper
• Myocardial late enhancement and extracellular volume with single-energy, dual-energy, and photon-counting computed tomography.

  2024cites this paper
• Cardiovascular multimodality imaging in women. A scientific statement of the European Association of Cardiovascular Imaging (EACVI) of the ESC.

  2024cites this paper
• Interstitial fibrosis and arrhythmic mitral valve prolapse: Unraveling sex-based differences

  2024cites this paper
• Cardiovascular Computed Tomography and Magnetic Resonance Imaging Guideline of the Brazilian Society of Cardiology and the Brazilian College of Radiology - 2024.

  2024cites this paper
• Multiparametric Cardiac Magnetic Resonance Imaging to Discriminate Endomyocardial Biopsy-Proven Chronic Myocarditis From Healed Myocarditis.

  2024cites this paper
• Utility of native T1 mapping and myocardial extracellular volume fraction in patients with nonischemic dilated cardiomyopathy: A systematic review and meta-analysis

  2024cites this paper
• A comparative study of synthetic and venous hematocrit for calculating cardiovascular magnetic resonance-derived extracellular volume

  2024cites this paper
• Magnetic resonance mapping for the assessment of cardiomyopathies and myocardial disease.

  2024cites this paper
• Assessment of Myocardial Fibrosis in Marfan Syndrome Using Cardiac Magnetic Resonance Imaging

  2024cites this paper
• Serial Extracellular Volume by Coronary Computed Tomography After Acute Myocardial Infarction With Left-Main Vasospasm

  2024cites this paper
• Distinguishing hypertensive cardiomyopathy from cardiac amyloidosis in hypertensive patients with heart failure: a CMR study with histological confirmation

  2024cites this paper
• Contemporary Multimodality Imaging for Diagnosis and Management of Fabry Cardiomyopathy

  2024cites this paper
• Usefulness of Native T1 in Cardiac Magnetic Resonance Imaging and Echocardiographic Strain Parameters for Detecting Early Cardiac Involvement in Fabry Cardiomyopathy

  2024cites this paper
• Tissue mapping by cardiac magnetic resonance imaging for the prognostication of cardiac amyloidosis: A systematic review and meta-analysis.

  2024cites this paper
• Free‐breathing, fat‐corrected T1 mapping of the liver with stack‐of‐stars MRI, and joint estimation of T1, PDFF, R2* , and B1+

  2024cites this paper
• Extracellular volume measured by whole body CT scans predicts chronic cardiotoxicity in breast cancer patients treated with neoadjuvant therapies based on anthracyclines: A retrospective study

  2024cites this paper
• Histological evaluation of cardiac remodelling in equine athletes

  2024cites this paper
• Cellular and Molecular Mechanisms Driving Cardiac Tissue Fibrosis: On the Precipice of Personalized and Precision Medicine.

  2024cites this paper
• Variation of computed tomography-derived extracellular volume fraction and the impact of protocol parameters: A systematic review and meta-analysis.

  2024cites this paper
• Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology

  2023cites this paper
• Myocardial Fibrosis: Emerging Target for Cardiac Molecular Imaging and Opportunity for Image-Guided Therapy.

  2023cites this paper
• The Additional Value of T1 Mapping in Cardiac Disease: State of the Art

  2023influential citation
• Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies.

  2023influential citation
• Aortic Stenosis and Amyloidosis: Role of MRI and CT in the Diagnosis of a Sneaky Association

  2023cites this paper
• Anderson-Fabry disease cardiomyopathy: an update on epidemiology, diagnostic approach, management and monitoring strategies

  2023cites this paper
• Hypertensive Heart Disease—The Imaging Perspective

  2023cites this paper
• Influence of cardiac cycle on myocardial extracellular volume fraction measurements with dual-layer computed tomography

  2023cites this paper
• PET/MRI Assessment of Acute Cardiac Inflammation 1 Month After Left-Sided Breast Cancer Radiation Therapy

  2023cites this paper
• Joint Cardiac T1 Mapping and Cardiac Cine Using Manifold Modeling

  2023cites this paper
• Cardiac MRI in Fabry disease

  2023influential citation
• Treatment of Fabry Disease: Established and Emerging Therapies

  2023cites this paper
• The Role of Cardiac MRI and Echocardiography in the Treatment of Cardiac Disorders in the Palestinian Health System

  2023cites this paper
• Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management

  2023cites this paper
• New Advanced Imaging Parameters and Biomarkers—A Step Forward in the Diagnosis and Prognosis of TTR Cardiomyopathy

  2022cites this paper
• Radiolabeled Thioflavin-T Derivative PET Imaging for the Assessment of Cardiac Amyloidosis.

  2022cites this paper
• Diffuse Myocardial Fibrosis Occurs in Young Patients with Sickle Cell Anemia Despite Early Disease Modifying Therapy.

  2022cites this paper
• A Left ventricle remodeling in patients with bicuspid aortic valve

  2022cites this paper
• Cardiac imaging techniques for the assessment of immune checkpoint inhibitor-induced cardiotoxicity and their potential clinical applications.

  2022cites this paper
• Comprehensive Cardiac Magnetic Resonance to Detect Subacute Myocarditis

  2022cites this paper
• Cardiac Magnetic Resonance in Fabry Disease: Morphological, Functional, and Tissue Features

  2022influential citation
• The Role of Cardiac Magnetic Resonance in patients with Amyloidosis and Aortic Stenosis

  2022cites this paper
• TRoponin of Unknown origin in STroke evaluated by multi-component cardiac Magnetic resonance Imaging – The TRUST-MI study

  2022cites this paper
• Using Multiparametric Cardiac Magnetic Resonance to Phenotype and Differentiate Biopsy-Proven Chronic from Healed Myocarditis and Dilated Cardiomyopathy

  2022cites this paper
• Joint cardiac $T_1$ mapping and cardiac function estimation using a deep manifold framework

  2022cites this paper
• Clinical application of CMR in cardiomyopathies: evolving concepts and techniques

  2022influential citation
• The utility of cardiac magnetic resonance imaging in the diagnosis of adult patients with acute myocarditis: A systematic review and meta-analysis.

  2022cites this paper
• Automated Dual-energy Computed Tomography-based Extracellular Volume Estimation for Myocardial Characterization in Patients With Ischemic and Nonischemic Cardiomyopathy

  2022cites this paper
• The Road Toward Reproducibility of Parametric Mapping of the Heart: A Technical Review

  2022cites this paper
• Theranostic Contribution of Extracellular Matrix Metalloprotease Inducer-Paramagnetic Nanoparticles Against Acute Myocardial Infarction in a Pig Model of Coronary Ischemia-Reperfusion

  2022cites this paper
• Role of Cardiac Magnetic Resonance in the Diagnosis of Infiltrative, Hypertrophic, and Arrhythmogenic Cardiomyopathies.

  2022cites this paper
• Measuring the Left Ventricular End-Diastolic Pressure: Out of Fashion But Still of Real Value

  2022cites this paper
• How to Perform a Diagnostic and Prognostic Analysis of Hypertrophic Cardiomyopathy in 2022: Should we Divide to Improve Treatment? DIC-SBC Women’s Group Difficulty Introducing Contrast Echocardiography in Daily Clinical Practice in South America: A Matter of Economy?

  2022cites this paper
• Disclosing the cardiomyopathic substrate within the heart muscles in amyloidosis by cardiac magnetic resonance: diagnostic and prognostic implications

  2022cites this paper
• Synthetic Extracellular Volume in Cardiac Magnetic Resonance Without Blood Sampling: a Reliable Tool to Replace Conventional Extracellular Volume

  2022cites this paper
• Correlation of serum ST2 levels with severity of diastolic dysfunction on echocardiography and findings on cardiac MRI in patients with heart failure with preserved ejection fraction

  2022cites this paper
• Role of cardiovascular magnetic resonance in the clinical evaluation of left ventricular hypertrophy: a 360° panorama

  2022cites this paper
• T1 Mapping and Extracellular Volume in Cardiomyopathy Showing Left Ventricular Hypertrophy: Differentiation Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease

  2022cites this paper
• Image resampling and discretization effect on the estimate of myocardial radiomic features from T1 and T2 mapping in hypertrophic cardiomyopathy

  2022cites this paper
• Hypertrophic Cardiomyopathy: A Review Using Magnetic Resonance Imaging

  2022cites this paper
• Improved accuracy and precision with three‐parameter simultaneous myocardial T1 and T2 mapping using multiparametric SASHA

  2022cites this paper
• The Utility of Advanced Cardiovascular Imaging in Cancer Patients—When, Why, How, and the Latest Developments

  2021cites this paper
• The Role of Cardiac Magnetic Resonance in Patients with Dilated Cardiomiopathy

  2021cites this paper
• CMR-based T1-mapping offers superior diagnostic value compared to longitudinal strain-based assessment of relative apical sparing in cardiac amyloidosis

  2021cites this paper
• T1 Mapping and Extracellular Volume Fraction in Dilated Cardiomyopathy: A Prognosis Study.

  2021cites this paper
• Measuring myocardial blood flow with 82rubidium using Gjedde–Patlak–Rutland graphical analysis

  2021cites this paper
• Diagnosis of Cardiac Involvement in Amyloid A Amyloidosis by Cardiovascular Magnetic Resonance Imaging

  2021cites this paper
• Extracellular volume quantification using synthetic haematocrit assessed from native and post-contrast longitudinal relaxation T1 times of a blood pool

  2021cites this paper
• Bone Tracers for the Diagnosis of Cardiac Amyloidosis

  2021cites this paper
• Technik und klinische Bedeutung des kardialen Mappings – was der Radiologe wissen sollte

  2021cites this paper
• Circulatory efficiency in patients with severe aortic valve stenosis before and after aortic valve replacement

  2021cites this paper
• Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathy.

  2021cites this paper
• Dual‐excitation flip‐angle simultaneous cine and T1 mapping using spiral acquisition with respiratory and cardiac self‐gating

  2021influential citation
• Diffuse myocardial fibrosis by T1 mapping is associated with heart failure in pediatric primary dilated cardiomyopathy.

  2021cites this paper
• Myocardial extracellular volume fraction quantification in an animal model of the doxorubicin-induced myocardial fibrosis: a synthetic hematocrit method using 3T cardiac magnetic resonance.

  2021influential citation
• Evaluation of Diastolic Function by Cardiac Magnetic Resonance Imaging

  2021cites this paper
• Proteoglycan Remodeling Is Accelerated in Females with Angina Pectoris and Diffuse Myocardial Fibrosis: the iPOWER Study

  2021cites this paper
• Improved Accuracy and Precision In Simultaneous Myocardial T1 and T2 mapping with Multi-Parametric SASHA (mSASHA)

  2021cites this paper
• Myocardial fibrosis in patients with a history of Kawasaki disease

  2021cites this paper
• Cardiovascular Magnetic Resonance Parametric Mapping Techniques: Clinical Applications and Limitations

  2021cites this paper